Renal Function, Diuretic Action, and Heart Failure: A Therapeutic Conundrum

Journal of Cardiac Failure

Volumn 13, Issue 9, 2007, Pages 698-700

  Sica, Domenic ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 (2 NOR 1 ADAMANTYL) 1,3 DIPROPYLXANTHINE; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

BLOOD PRESSURE; DIURETIC ACTIVITY; EDITORIAL; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; PRIORITY JOURNAL;

DISEASE PROGRESSION; DIURETICS; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; RECEPTOR, ADENOSINE A1; RENAL INSUFFICIENCY; RISK FACTORS;

EID: 35748950399     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2007.10.001     Document Type: Editorial

References (14)

1. Smith G.L., Shlipak M.G., Havranek E.P., et al. Race and renal impairment in heart failure: mortality in blacks versus whites. Circulation 111 (2005) 1270-1277
2. Smith G.L., Lichtman J.H., Bracken M.B., et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47 (2006) 1987-1996
3. de Silva R., Nikitin N.P., Witte K.K., et al. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur Heart J 27 (2006) 569-581
4. Damman K., Navis G., Voors A.A., et al. Worsening renal function and prognosis in heart failure. J Card Fail 13 (2007) 599-608
5. Arimoto T., Takeishi Y., Niizeki T., et al. Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure. J Card Fail 11 (2005) 595-601
6. Hillege H.L., Girbes A.R., de Kam P.J., et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102 (2000) 203-210
7. Dittrich H., Gupta D.K., Hack T.C., et al. The effect of KW-3092, an adenosine A1 receptor antagonist in ambulatory patients with heart failure and renal impairment. J Card Fail 13 (2007) 609-617
8. Kriz W. Adenosine and ATP: traffic regulators in the kidney. J Clin Invest 114 (2004) 611-613
9. Vallon V., Muhlbauer B., and Osswald H. Adenosine and kidney function. Physiol Rev 86 (2006) 901-940
10. Sica D.A., and Gehr T.W. Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships. Clin Pharmacokinet 30 (1996) 229-249
11. Gottlieb S.S., Brater D.C., Thomas I., et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 105 (2002) 1348-1353
12. Colleta L., Tin P., Loh A., et al. Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902. Eur J Heart Fail 8 (2007) 547-549
13. Givertz M.M., Massie B.M., Fields T.K., et al. The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol 50 (2007) 1551-1560
14. Boison D. Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. Neuroscientist 11 (2005) 25-36